Table 3.

Respondents decisions to alter or extend research due to Canadian regulation barriers (N = 93).

	Public sector			Private sector
	Agree	Disagree	No response	Agree	Disagree	No response
I decided not to undertake a research proposal or develop an innovation because I self-determined the innovation would be considered novel.	22%	31%	5%	12%	17%	13%
I altered my/our breeding objective to avoid having a product reviewed as novel in Canada.	15%	32%	11%	4%	20%	17%
I had a product in a pathway to commercialization in Canada, but I did not proceed as I found out the product would be considered novel.	3%	38%	17%	3%	22%	17%
I conducted extra research to provide evidence to Canadian regulators that our innovation should not be considered novel.	8%	31%	19%	13%	15%	14%
I experienced delays introducing a new variety in Canada compared to other markets due to the novelty trigger.	9%	27%	23%	9%	16%	17%